Lakefront Biotherapeutics | GLPG - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
argenx SE USD 426M 22.71M 2026-03
AstraZeneca USD 4.81B 894M 2026-06
Biogen USD 647.3M 269.6M 2026-06
Genmab DKK 295M 221M 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
GRIFOLS EUR 247M 135M 2026-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Incyte USD 751.51M 407.91M 2026-06
Merck EUR 869M 468M 2026-03
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 4.27B 430M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR 837M 1.17B 2026-06
UCB EUR 789M 427M 2025-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06